Tag

Iloprost

All articles tagged with #iloprost

health2 years ago•2 min saved

"FDA Approves First Medication to Prevent Frostbite Amputation"

The FDA has approved Aurlumyn (iloprost) injection as a treatment for severe frostbite in adults to reduce the risk of finger or toe amputation. Iloprost, the active ingredient, is a vasodilator that prevents blood clotting. This approval provides the first-ever treatment option for severe frostbite in the United States, offering a significant advancement in frostbite treatment. Existing clot-bursting medications come with high risks and are effective for only around 24 hours post-frostbite, while iloprost has been used safely and effectively in other countries for years.

via Good News Network|

#amputation #aurlumyn #fda

health2 years ago•1 min saved

"Breakthrough Drug Aurlumyn Offers Hope for Frostbite Amputation Prevention"

The FDA has approved the first medication for treating severe frostbite in adults, a condition that can lead to amputations. The injectable drug, Aurlumyn, made by Eicos Sciences, contains iloprost, a vasodilator that opens blood vessels and prevents clotting. Severe frostbite, caused by exposure to freezing temperatures, can lead to disabled patients and disproportionately affects the homeless population. In a clinical trial, none of the patients who received only the new drug required amputations, compared to those who received other medications. Aurlumyn is expected to be available this spring, with the price yet to be determined.

via The Washington Post|

#aurlumyn #fda #frostbite

health2 years ago•2 min saved

"FDA Approves Breakthrough Drug to Treat Severe Frostbite and Prevent Amputation"

The FDA has approved the first therapy for severe frostbite, a drug called iloprost, which is administered intravenously over a little more than a week. This treatment works by improving circulation, limiting inflammation, and preventing the formation of clots that can kill tissue. Severe frostbite cases, which can affect toes, fingers, ears, cheeks, and nose, are relatively uncommon, but the approval of this treatment marks a significant advancement in the field of cold-weather injury care.

via The New York Times|

#amputation #fda-approval #frostbite

health2 years ago•3 min saved

"FDA Greenlights First-Ever Drug for Severe Frostbite Treatment"

The FDA has approved the first drug, iloprost (Aurlumyn), to treat severe frostbite, marking a significant breakthrough as there were previously no approved therapies for this condition. Iloprost, originally used to treat high blood pressure in the lungs, has shown promising results in a clinical trial, with 0% of patients receiving the drug requiring amputation compared to 60% of those who did not. The drug works by expanding blood vessels and reducing oxidative stress, potentially preventing life-altering amputations for patients with severe frostbite.

via ScienceAlert|

#drug-approval #fda #frostbite

health2 years ago•3 min saved

"FDA Approves First Drug for Severe Frostbite Treatment"

The FDA has approved the first drug, iloprost, to treat severe frostbite in adults, reducing the need for amputation. Severe frostbite occurs when body parts freeze after exposure to temperatures below 32 degrees Fahrenheit, leading to reduced blood flow and tissue damage. Iloprost opens up blood vessels and prevents blood clotting, providing a new treatment option for severe frostbite with promising results from a recent clinical trial.

via Livescience.com|

#amputation #fda #frostbite

health2 years ago•2 min saved

"FDA Approves First Drug for Severe Frostbite"

The FDA has approved the first medication, iloprost (brand name Aurlumyn), to treat severe frostbite, reducing the risk of finger and toe amputations due to dangerously cold extremities. This vasodilator drug, originally approved for pulmonary arterial hypertension, prevents blood clotting and preserves blood flow, as shown in a clinical trial where patients who received iloprost did not require amputation. Developed by Eicos Sciences Inc., the drug may cause side effects and must be administered by a physician.

via New York Post |

#aurlumyn #fda #frostbite

health2 years ago•3 min saved

"FDA Grants First-Ever Approval for Severe Frostbite Medication"

The FDA has approved the first medication, iloprost (brand name Aurlumyn), to treat severe frostbite, aiming to reduce the risk of finger and toe amputations due to dangerously cold extremities. Iloprost, originally approved for pulmonary arterial hypertension, is a vasodilator that preserves blood flow and prevents clotting in the affected areas. In a clinical trial, patients who received iloprost did not require amputation, unlike those who received other medications. However, the drug may cause side effects and must be administered by a physician.

via Fox News|

#aurlumyn #fda #frostbite